Generic drugmaker Dr Reddy's Laboratories reported a 36% year-on-year (YoY) decline in net profit to Rs 913.4 crore for the September quarter, compared with Rs 1,426.8 crore in the corresponding quarter last year.
Revenue fell 1.5% YoY to Rs 8,671 crore from Rs 8,805.1 crore. EBITDA declined 24.2% to Rs 1,783 crore from Rs 2,351.1 crore, while the EBITDA margin contracted to 20.6% from 26.7% a year earlier, according to the exchange filing submitted by the company.
